BAVARIAN NORDIC A/S

APOXTRA

PHARMACEUTICAL PREPARATION;

BAVABOOST

Pharmaceutical preparations and compositions, including vaccines for prophylactic use and the treatment of infectious diseases, including Corona, COVID, and COVID19 viral diseases;

BAVARIAN NORDIC

PHARMACEUTICAL AND VETERINARY PREPARATIONS, namely, PREPARATIONS FOR THE TREATMENT AND PREVENTION OF POXVIRUS DISEASES, PREPARATIONS FOR THE TREATMENT AND PREVENTION OF SMALLPOX, PREPARATIONS FOR THE TREATMENT AND PREVENTION OF ALLERGIES; PREPARATIONS FOR STIMULATING AND MODULATING THE IMMUNE SYSTEM; PREPARATIONS FOR ACCELERATING THE MATURATION OF THE IMMUNE SYSTEM; PREPARATIONS FOR THE TREATMENT AND PREVENTION OF CANCER, AIDS, [PNEUMONIA, BRONCHIOLITIS, ASTHMA,] DENGUE FEVER, [RHEUMATISM,] [ARTHRITIS,] [NEURITIS, PSORIASIS] AND ALLERGIC SKIN ECZEMA, [DEMENTIA,] [MENTAL RETARDATION DISEASES;] VACCINES, VACCINE ADJUVANTS; DRUG DELIVERY AGENTS CONSISTING OF COMPOUNDS THAT FACILITATE DELIVERY OF A WIDE RANGE OF PHARMACEUTICALS;BIOCHEMICALS, NAMELY, PRECURSORS FOR IN VITRO GENETIC ENGINEERING USE; BIOCHEMICALS, NAMELY, POLYPEPTIDES FOR IN VITRO RESEARCH USE[; BIOCHEMICALS, NAMELY, MONOCLONAL ANTIBODIES FOR IN VITRO RESEARCH OR SCIENTIFIC USE; CATALYSTS FOR CHEMICAL MID BIOCHEMICAL PROCESSES];Development of vaccines and pharmaceutical and veterinary preparations;

COMVAT

Pharmaceutical and veterinary preparation, vaccines;

CV301

Preparations for the treatment and prevention of cancer; vaccines; vaccines against tumor diseases; vaccines to induce a general immune stimulation; vaccine vectors; vaccine adjuvants; pharmaceutical and/or medical preparations, namely pharmaceutical preparations used to stimulate the immune system; pharmaceutical and/or medical preparations, namely pharmaceutical preparations for allowing the expression of a therapeutic and immunogenic gene product to treat and prevent cancerous diseases;

ELSTREE-BN

PHARMACEUTICAL AND VETERINARY PREPARATIONS, NAMELY, PREPARATIONS TO TREAT AND/OR PREVENT DISEASES INDUCED BY INFECTIOUS AGENTS SUCH AS VIRUSES, PREPARATIONS TO TREAT AND/OR PREVENT TUMOR DISEASES, PREPARATIONS TO STIMULATE THE IMMUNE SYSTEM, PREPARATIONS TO MODULATE THE IMMUNE SYSTEM, PREPARATIONS ALLOWING THE TRANSIENT EXPRESSION OF THERAPEUTIC GENE PRODUCTS AFTER ADMINISTRATION OF SAID PREPARATIONS TO TREAT DISEASES IN WHICH THE TRANSIENT EXPRESSION OF THE THERAPEUTIC GENE PRODUCT HAS A BENEFICIAL EFFECT;ELSTREE BAVARIAN NORDIC;

EMVAREX

Vaccines against infectious diseases; vaccines against viral infections; vaccines against bacterial infections; veterinary vaccines; pharmaceutical and veterinary preparations for the treatment of infectious diseases, viral infections and bacterial infections;

EMVASAN

In the statement, Column 1, Line 3, Bqegeskovvej is deleted, and, Boegeskovvej is inserted.;Vaccines against infectious diseases; vaccines against viral infections; vaccines against bacterial infections; vaccines to prevent tumor diseases; veterinary vaccines; pharmaceutical and veterinary preparations for the treatment of infectious diseases, viral infections, bacterial infections, tumor diseases, and for general immune stimulation;

ENCEPUR

The mark consists of a designed letter E with the words Encepur to the right of the designed letter E.;Vaccines; Adjuvants for use with vaccines; Pharmaceutical preparations for the prevention of Tick-Borne Encephalitis (TBE); Pharmaceutical preparations for the treatment of Tick-Borne Encephalitis (TBE); Veterinary pharmaceutical preparations for the prevention of Tick-Borne Encephalitis (TBE); Veterinary pharmaceutical preparations for the treatment of Tick-Borne Encephalitis (TBE);